News Home

Should Diagnostics & Research Stock OpGen Inc (OPGN) Be in Your Portfolio Tuesday?

Tuesday, March 30, 2021 02:31 PM | InvestorsObserver Analysts
Should Diagnostics & Research Stock OpGen Inc (OPGN) Be in Your Portfolio Tuesday?

OpGen Inc (OPGN) is near the top in its industry group according to InvestorsObserver. OPGN gets an overall rating of 53. That means it scores higher than 53 percent of stocks. OpGen Inc gets a 76 rank in the Diagnostics & Research industry. Diagnostics & Research is number 91 out of 148 industries.

Overall Score - 53
OPGN has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on OPGN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 53 would rank higher than 53 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With OpGen Inc Stock Today?

OpGen Inc (OPGN) stock is trading at $2.49 as of 2:28 PM on Tuesday, Mar 30, a decline of -$0.18, or -6.58% from the previous closing price of $2.66. The stock has traded between $2.44 and $2.60 so far today. Volume today is less active than usual. So far 1,975,191 shares have traded compared to average volume of 18,853,763 shares.

Click Here to get the full Stock Score Report on OpGen Inc (OPGN) Stock.

You May Also Like